UNIGE document Scientific Article
previous document  unige:4586  next document
add to browser collection

17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30

Vivacqua, Adele
Bonofiglio, Daniela
Albanito, Lidia
Madeo, Antonio
Rago, Vittoria
Carpino, Amalia
Musti, Anna Maria
show hidden authors show all authors [1 - 10]
Published in Molecular Pharmacology. 2006, vol. 70, no. 4, p. 1414-23
Abstract The higher incidence of thyroid carcinoma (TC) in women during reproductive years compared with men and the increased risk associated with the therapeutic use of estrogens have suggested a pathogenetic role exerted by these steroids in the development of TC. In the present study, we evaluated the potential of 17beta-estradiol (E2), genistein (G), and 4-hydroxyta-moxifen (OHT) to regulate the expression of diverse estrogen target genes and the proliferation of human WRO, FRO, and ARO thyroid carcinoma cells, which were used as a model system. We have ascertained that ARO cells are devoid of estrogen receptors (ERs), whereas both WRO and FRO cells express a single variant of ERalpha that was neither transactivated, modulated, nor translocated into the nucleus upon treatment with ligands. However, E2, G, and OHT were able either to induce the transcriptional activity of c-fos promoter constructs, including those lacking the estrogen-responsive elements, or to increase c-fos, cyclin A, and D1 expression. It is noteworthy that we have demonstrated that the G protein-coupled receptor 30 (GPR30) and the mitogen-activated protein kinase (MAPK) pathway mediate both the up-regulation of c-fos and the growth response to E2, G, and OHT in TC cells studied, because these stimulatory effects were prevented by silencing GPR30 and using the MEK inhibitor 2'-amino-3'-methoxyflavone (PD 98059). Our findings provide new insight into the molecular mechanisms through which estrogens may induce the progression of TC.
Keywords Antineoplastic Agents/pharmacologyCarcinoma/genetics/metabolismCell Line, TumorCell ProliferationCyclin A/metabolismCyclin D1/metabolismEstradiol/pharmacologyGene Expression Regulation, NeoplasticGenistein/pharmacologyHumansPromoter Regions, GeneticProto-Oncogene Proteins c-fos/genetics/metabolismRNA, Messenger/metabolismReceptors, Estrogen/metabolismReceptors, G-Protein-Coupled/metabolismSignal TransductionTamoxifen/analogs & derivatives/pharmacologyThyroid Neoplasms/genetics/metabolismTransfection
PMID: 16835357
Full text
Article (Published version) (584 Kb) - document accessible for UNIGE members only Limited access to UNIGE
(ISO format)
VIVACQUA, Adele et al. 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30. In: Molecular Pharmacology, 2006, vol. 70, n° 4, p. 1414-23. doi: 10.1124/mol.106.026344 https://archive-ouverte.unige.ch/unige:4586

859 hits

0 download


Deposited on : 2009-12-03

Export document
Format :
Citation style :